"La clinique Beau Soleil dispose d'une unité d'hospitalisation de 180 lits et d'un vaste pôle de consultations externes. Parmi les équipements innovants dont elle est dotée, il y a le robot chirurgical Da Vinci, qui permet un contrôle très fin des instruments, pour des gestes opératoires jusqu’alors impossibles. Aujourd'hui, la clinique Beau Soleil se modernise. Elle a lancé un vaste programme d'aménagement et d'extension. L'objectif est de créer une véritable cité de la santé et du bien-être au cœur de Montpellier."

During the past decade, Clinique Beau Soleil conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 4 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Beau Soleil" #1 sponsor was "Centre Hospitalier Universitaire de Nīmes" with 7 trials, followed by "Clinique Beau Soleil" with 7 trials sponsored, "ASTORA Women's Health" with 2 trials sponsored, "Ferring Pharmaceuticals" with 2 trials sponsored and "Groupe Francophone des Myelodysplasies" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Beau Soleil" #1 collaborator was "Janssen-Cilag Ltd." with 2 trials as a collaborator, "Team Languedoc Mutualité / Nouvelles technologies" with 2 trials as a collaborator, "University Hospital, Montpellier" with 2 trials as a collaborator, "Agence Nationale de sécurité du Médicament" with 1 trials as a collaborator and "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Beau Soleil" are "Prostate Cancer" (5 trials), "Pelvic Organ Prolapse" (4 trials), "Parkinson Disease" (3 trials), "MDS" (2 trials) and "Adenocarcinoma of the Prostate" (1 trials). Many other conditions were trialed in "Clinique Beau Soleil" in a lesser frequency.

Most popular intervention types in "Clinique Beau Soleil" are "Drug" (13 trials), "Device" (9 trials), "Other" (8 trials), "Procedure" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apomorphine" (2 trials), "Tofacitinib" (2 trials), "1 month of PDE5i treatment" (1 trials), "4 weekly LIESWT (Wave 1) with the RENOVA device" (1 trials) and "4 weekly sham LIESWT (Wave 1) with the RENOVA device" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Beau Soleil" are 18 trials for "All" genders, 12 trials for "Male" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Clinique Beau Soleil". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Clinique Beau Soleil, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Beau Soleil, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 12 trials that are defined as “Not Applicable".